CVERGENX, in collaboration with investigators at the Moffitt Cancer Center, has developed a unique molecular diagnostic assay that identifies differences in tumor radiosensitivity, which allows the appropriate selection of patients most likely to benefit from Radiation Therapy.
DeMelle OncoPharma, LLC
A specialty pharmaceutical company that is developing new formulations of Farnesyl DiMethyl Chromanol for the treatment and prevention of pancreatic cancer.
Saïd Sebti, Nick Lawrence
We are a start-up company based in Jupiter, Florida and we are focused on the treatment of cancer using novel compound technologies discovered at the Moffitt Cancer Center in Tampa, Florida and exclusively licensed by us from them.
Marco L. Davila, Gongbo Li
ImmuneBro Therapeutics is developing simple and novel off-the-shelf T cell therapy for cancer.
We are dedicated towards improving patient outcomes by developing novel approaches for targeting cell adhesion molecules critical for mediating drug resistance and survival of tumor cells.
OncoBay Clinical is a boutique contract research boutique contract research organization (CRO) specializing in immuno-oncology/cell therapy, offering full- service custom-curated CRO solutions for global pharmaceutical and biotech companies looking to advance their immuno-oncology product or device.
Nupam Mahajan, Kiran Mahajan
A molecular diagnostics company developing Akt and histone phosphorylation tests for predicting response to therapies.
A medical device company developing an improved wide band tourniquet for blood draws.
Cambiar el idioma
Si no encuentra la información que busca o si desea programar una cita, llámenos gratis al 1-888-663-3488.